Age-Related Adaptive Immune Changes in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Abstract
Ageing is a major risk factor for most neurodegenerative diseases, including Parkinson’s disease (PD). Progressive age-related dysregulation of the immune system is termed immunosenescence and is responsible for the weakened response to novel antigens, increased susceptibility to infections and reduced effectiveness of vaccines seen in the elderly. Immune activation, both within the brain and periphery, is heavily implicated in PD but the role of immunosenescence has not been fully explored. Studies to date provide some evidence for an attenuation in immunosenescence in PD, particularly a reduction in senescent CD8 T lymphocytes in PD cases compared to similarly aged controls. Here, we discuss recent evidence of age-related immune abnormalities in PD with a focus on T cell senescence and explore their potential role in disease pathogenesis and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, during abnormal immune ageing, the typical age-associated shift towards senescence in the CD8+ T-cell population may be attenuated, resulting in a heightened immune response to misfolded α-syn and thereby increasing the risk of PD.333”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · cited 1×
“Both alpha-synuclein pathology and microbial changes in the gut have also been implicated in driving a proinflammatory state in PD [66, 67].”
BackgroundAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 1×
“Ageing is characterized by a gradual deterioration of biological functions and is the main risk factor for multiple pathological conditions, such as cardiovascular disease [1], cancer [2], and neurodegenerative disorders [3].”
BackgroundAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · cited 1×
“found a significantly higher mortality rate in people whose leucocytes had the greatest degree of telomere erosion [47].”
BackgroundBrochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Postuma, R. B., Iranzo, A., Hu, M., Högl, B., Boeve, B. F., Manni, R., Oertel, W. H., Arnulf, I., Ferini-Strambi, L., Puligheddu, M., et al. (2019) · Brain · doi:10.1093/brain/awz030 · Cited by 1,106 · cited 1×
“Interestingly, a proteomic study in a small group of patients with REM sleep behaviour disorder (who have a 60–81% likelihood of developing parkinsonism/dementia within 10 years) [55, 56] has reported a significant upregulation of CRP as well as other immune-related molecules in patients versus controls, thus implicat…”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064 · cited 1×
“Immunosenescence contributes to increased susceptibility to infections, reduced effectiveness of vaccines [4], as well as increased prevalence of autoimmunity and inflammatory conditions in the elderly [5].”
BackgroundClonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
Gate, D., Saligrama, N., Leventhal, O., Yang, A. C., Unger, M. S., Middeldorp, J., Chen, K., Lehallier, B., Channappa, D., De Los Santos, M. B., et al. (2020) · Nature · doi:10.1038/s41586-019-1895-7 · Cited by 992 · cited 1×
“RAs in the CSF of patients versus controls [70].”
BackgroundGoodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008) · Movement Disorders · doi:10.1002/mds.21922 · Cited by 922 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Schenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.009 · Cited by 814 · cited 1×
“Interestingly, a proteomic study in a small group of patients with REM sleep behaviour disorder (who have a 60–81% likelihood of developing parkinsonism/dementia within 10 years) [55, 56] has reported a significant upregulation of CRP as well as other immune-related molecules in patients versus controls, thus implicat…”
BackgroundHamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784 · cited 1×
“This idea is supported by the well described genetic association between immune loci, particularly those involved in antigen presentation such as the Human Leucocyte Antigen region, and PD risk [79, 80].”
BackgroundKhan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J. A., Sinclair, A. J., Nayak, L., & Moss, P. A. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1984 · Cited by 754
Geginat, J., Lanzavecchia, A., & Sallusto, F. (2003) · Blood · doi:10.1182/blood-2002-11-3577 · Cited by 601 · cited 1×
“These senescent cells are highly oligoclonal, have a diminished capacity to proliferate, and are proinflammatory [16, 17].”
BackgroundThe gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588 · cited 1×
“Both alpha-synuclein pathology and microbial changes in the gut have also been implicated in driving a proinflammatory state in PD [66, 67].”
BackgroundQin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554
Panda, A., Qian, F., Mohanty, S., van Duin, D., Newman, F. K., Zhang, L., Chen, S., Towle, V., Belshe, R. B., Fikrig, E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901022 · Cited by 548 · cited 1×
“Both cell types, however, have shown an attenuated secretion of pro-inflammatory cytokines upon Toll-like receptors stimulation in the elderly [39], suggesting immunosenescence of dendritic cells occurs with ageing.”
BackgroundThymic involution and immune reconstitution.
Lynch, H. E., Goldberg, G. L., Chidgey, A., Van den Brink, M. R. M., Boyd, R., & Sempowski, G. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.003 · Cited by 522 · cited 1×
“This results in a reduction in the naı̈ve T cell pool that is able to respond and clonally expand when encountering novel antigens [26].”
BackgroundDutertre, C.-A., Becht, E., Irac, S. E., Khalilnezhad, A., Narang, V., Khalilnezhad, S., Ng, P. Y., van den Hoogen, L. L., Leong, J. Y., Lee, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.008 · Cited by 520
The Effect of Age on Thymic Function
Palmer, D. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00316 · Cited by 494 · cited 1×
“Thymic involution has been shown to start very early on in life and continue exponentially over time [24, 25].”
BackgroundHadrup, S. R., Strindhall, J., Køllgaard, T., Seremet, T., Johansson, B., Pawelec, G., thor Straten, P., & Wikby, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2645 · Cited by 471
Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?
Duggal, N. A., Niemiro, G., Harridge, S. D. R., Simpson, R. J., & Lord, J. M. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0177-9 · Cited by 436
CD28 extinction in human T cells: altered functions and the program of T‐cell senescence
Vallejo, A. N. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00256.x · Cited by 431 · cited 1×
“Indeed replicative CD8 T cell senescence, as defined by the loss of CD28 expression, has been shown to be associated with shortened telomeres [45, 46].”
Backgroundα-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Effros, R. B., Boucher, N., Porter, V., Zhu, X., Spaulding, C., Walford, R. L., Kronenberg, M., Cohen, D., & Schächter, F. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90073-6 · Cited by 377
Monteiro, J., Batliwalla, F., Ostrer, H., & Gregersen, P. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3587 · Cited by 376 · cited 1×
“Indeed replicative CD8 T cell senescence, as defined by the loss of CD28 expression, has been shown to be associated with shortened telomeres [45, 46].”
BackgroundFrom “truly naïve” to “exhausted senescent” T cells: When markers predict functionality
Larbi, A., & Fulop, T. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22351 · Cited by 359
Cancer as a disease of old age: changing mutational and microenvironmental landscapes
Laconi, E., Marongiu, F., & DeGregori, J. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0721-1 · Cited by 348 · cited 1×
“Ageing is characterized by a gradual deterioration of biological functions and is the main risk factor for multiple pathological conditions, such as cardiovascular disease [1], cancer [2], and neurodegenerative disorders [3].”
BackgroundAlterations of T-lymphocyte populations in Parkinson disease
Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K., & Yamada, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.005 · Cited by 336 · cited 1×
“Baba and colleagues reported a significant decrease in the CD4:CD8 T cell ratio in PD patients compared to age-matched controls [35], while Bas et al.”
ResultCD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Saunders, J. A. H., Estes, K. A., Kosloski, L. M., Allen, H. E., Dempsey, K. M., Torres-Russotto, D. R., Meza, J. L., Santamaria, P. M., Bertoni, J. M., Murman, D. L., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9402-z · Cited by 323
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323 · cited 2×
“cytomegalovirus (CMV) has been strongly associated with CD8 T cell senescence in the elderly [11].”
BackgroundSerum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J. R., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 304
Self-citationGoronzy, J. J., & Weyand, C. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0970-0 · Cited by 292 · cited 1×
“Immunosenescence contributes to increased susceptibility to infections, reduced effectiveness of vaccines [4], as well as increased prevalence of autoimmunity and inflammatory conditions in the elderly [5].”
BackgroundSenescence of T Lymphocytes: Implications for Enhancing Human Immunity
Akbar, A. N., Henson, S. M., & Lanna, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.002 · Cited by 285 · cited 1×
“These senescent cells are highly oligoclonal, have a diminished capacity to proliferate, and are proinflammatory [16, 17].”
BackgroundJing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S., & Deng, Y. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.005 · Cited by 284 · cited 1×
“In the healthy population, advancing age is associated with a decrease in the numbers of plasmacytoid dendritic cells, whilst the population of myeloid dendritic cells remains largely unchanged [38].”
BackgroundLindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276 · cited 1×
“Higher levels of CRP and monocyte chemoattractant protein-1 have also been reported to be closely linked to the development of cognitive impairment, depression and fatigue in PD [62].”
BackgroundCD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267
Markers of T Cell Senescence in Humans
Xu, W., & Larbi, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081742 · Cited by 261 · cited 1×
“Chronic stimulation of T cells with CMV in vitro triggers clonal expansion followed by further differentiation; eventually these antigen-experienced T cells lose their ability to proliferate, display an altered phenotype and reach a stage of replicative senescence [18].”
BackgroundIdentification of a human recent thymic emigrant phenotype
McFarland, R. D., Douek, D. C., Koup, R. A., & Picker, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070061597 · Cited by 252 · cited 1×
“An indirect and non-invasive method of quantifying thymic function and T cell output is by measuring the number of naı̈ve CD4 and CD8 recent thymic emigrant T cells using flow cytometry [51, 52].”
MethodCD57+ T lymphocytes and functional immune deficiency
Focosi, D., Bestagno, M., Burrone, O., & Petrini, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809566 · Cited by 252
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
Bas, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00422-7 · Cited by 250 · cited 1×
“showed a reduction in the proportion and absolute number of naı̈ve CD45RA+ CD4 T cells in PD versus controls [36].”
BackgroundWu, P.-L., Lee, M., & Huang, T.-T. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181515 · Cited by 243 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundMeta-analysis of Telomere Length in Alzheimer’s Disease
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw053 · Cited by 229 · cited 1×
“This was demonstrated in a meta-analysis including 860 patients and 2022 healthy subjects across 13 studies (9 of which were done in leucocytes) [73].”
MethodImmunosenescence: deficits in adaptive immunity in the elderly
Hakim, F. T., & Gress, R. E. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00891.x · Cited by 219 · cited 1×
“Progressive atrophy of the thymus, a lymphoid organ vital for the maturation of T lymphocytes, is another prominent characteristic of the ageing immune system [23].”
BackgroundImmunosenescence Study of T Cells: A Systematic Review
Rodriguez, I. J., Lalinde Ruiz, N., Llano León, M., Martínez Enríquez, L., Montilla Velásquez, M. D. P., Ortiz Aguirre, J. P., Rodríguez Bohórquez, O. M., Velandia Vargas, E. A., Hernández, E. D., & Parra López, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604591 · Cited by 217
When aging reaches CD4+ T-cells: phenotypic and functional changes
Moro-García, M. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00107 · Cited by 213 · cited 1×
“These changes include a reduction in the CD4:CD8 ratio, a decline in antigeninexperienced naı̈ve T cells and an accumulation of antigen-experienced and late differentiated cells [34].”
BackgroundDramatic Shifts in Circulating CD4 but not CD8 T Cell Subsets in Mild Alzheimer's Disease
Larbi, A., Pawelec, G., Witkowski, J. M., Schipper, H. M., Derhovanessian, E., Goldeck, D., & Fulop, T. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1015 · Cited by 209
Trollor, J. N., Smith, E., Agars, E., Kuan, S. A., Baune, B. T., Campbell, L., Samaras, K., Crawford, J., Lux, O., Kochan, N. A., et al. (2012) · AGE · doi:10.1007/s11357-011-9301-x · Cited by 204
The Effects of Physical Activity in Parkinson’s Disease: A Review
Lauzé, M., Daneault, J.-F., & Duval, C. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160790 · Cited by 204 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundPeripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
King, E., O’Brien, J. T., Donaghy, P., Morris, C., Barnett, N., Olsen, K., Martin-Ruiz, C., Taylor, J.-P., & Thomas, A. J. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317134 · Cited by 190 · cited 1×
“A subsequent study reported a similar increase in cytokine levels (IL-1 , IL-10, IL-4, and IL-2) in patients with mild cognitive impairment (MCI) with a Lewy body profile and in patients with MCI with an Alzheimer’s disease (AD) profile, as compared to controls [54].”
Haines, C. J., Giffon, T. D., Lu, L.-S., Lu, X., Tessier-Lavigne, M., Ross, D. T., & Lewis, D. B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080996 · Cited by 189 · cited 1×
“An indirect and non-invasive method of quantifying thymic function and T cell output is by measuring the number of naı̈ve CD4 and CD8 recent thymic emigrant T cells using flow cytometry [51, 52].”
Methodda Silva, F. C., Iop, R. D. R., de Oliveira, L. C., Boll, A. M., de Alvarenga, J. G. S., Gutierres Filho, P. J. B., de Melo, L. M. A. B., Xavier, A. J., & da Silva, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193113 · Cited by 189 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundNeuroinflammation and protein pathology in Parkinson’s disease dementia
Kouli, A., Camacho, M., Allinson, K., & Williams-Gray, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01083-5 · Cited by 189
Self-citationDerhovanessian, E., Maier, A. B., Hähnel, K., Beck, R., de Craen, A. J. M., Slagboom, E. P., Westendorp, R. G. J., & Pawelec, G. (2011) · Journal of General Virology · doi:10.1099/vir.0.036004-0 · Cited by 186 · cited 1×
“Both CD8 TEMRA and CD28loCD57hi T cell populations are increased in elderly CMV seropositive populations [19, 20].”
BackgroundAltered lymphocyte distribution in Alzheimer’s disease
RICHARTZSALZBURGER, E., BATRA, A., STRANSKY, E., LASKE, C., KOHLER, N., BARTELS, M., BUCHKREMER, G., & SCHOTT, K. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.010 · Cited by 167 · cited 1×
“Similar to PD, an overall reduction in the proportion of total T and B lymphocytes has been reported in AD patients compared to matched controls [68].”
ResultFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.12.001 · Cited by 160
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
Karayel, O., Virreira Winter, S., Padmanabhan, S., Kuras, Y. I., Vu, D. T., Tuncali, I., Merchant, K., Wills, A.-M., Scherzer, C. R., & Mann, M. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100661 · Cited by 156
Hall, S., Janelidze, S., Surova, Y., Widner, H., Zetterberg, H., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-31517-z · Cited by 155 · cited 7×
“Higher levels of CRP and monocyte chemoattractant protein-1 have also been reported to be closely linked to the development of cognitive impairment, depression and fatigue in PD [62].”
BackgroundInfluentialIncreased CSF biomarkers of angiogenesis in Parkinson disease
Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002151 · Cited by 150
Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143 · cited 1×
“Alpha-synuclein aggregates, which are known to circulate in peripheral blood in PD [64], can induce a peripheral inflammatory response via Toll-like receptor activation [65].”
BackgroundSelf-citationNonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review
Hindle, J. V., Petrelli, A., Clare, L., & Kalbe, E. (2013) · Movement Disorders · doi:10.1002/mds.25377 · Cited by 140 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundImmune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134 · cited 2×
“seemed to be driven by a higher percentage of activated CD8 T cells (CD8+ HLA+) [84].”
BackgroundCSF Cytokines in Aging, Multiple Sclerosis, and Dementia
Hu, W. T., Howell, J. C., Ozturk, T., Gangishetti, U., Kollhoff, A. L., Hatcher-Martin, J. M., Anderson, A. M., & Tyor, W. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00480 · Cited by 122 · cited 12×
“Proteomic studies in CSF have also shown an increase of HLA proteins (HLA-DRA, HLA-DRB1 and HLA-DPA1) [63] in familial PD patients (LRRK2 G2019S carriers) versus controls, providing further evidence of increased inflammation in PD.”
BackgroundInfluentialWang, P., Yao, L., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00280-3 · Cited by 121 · cited 12×
“Proteomic studies in CSF have also shown an increase of HLA proteins (HLA-DRA, HLA-DRB1 and HLA-DPA1) [63] in familial PD patients (LRRK2 G2019S carriers) versus controls, providing further evidence of increased inflammation in PD.”
BackgroundInfluentialAging-induced biological changes and cardiovascular diseases.
Fajemiroye, J. O., Cunha, L. C. D., Saavedra-Rodríguez, R., Rodrigues, K. L., Naves, L. M., Mourão, A. A., Silva, E. F. D., Williams, N. E. E., Martins, J. L. R., Sousa, R. B., et al. (2018) · BioMed Research International · doi:10.1155/2018/7156435 · Cited by 109 · cited 1×
“Ageing is characterized by a gradual deterioration of biological functions and is the main risk factor for multiple pathological conditions, such as cardiovascular disease [1], cancer [2], and neurodegenerative disorders [3].”
BackgroundÁlvarez-Luquín, D. D., Arce-Sillas, A., Leyva-Hernández, J., Sevilla-Reyes, E., Boll, M. C., Montes-Moratilla, E., Vivas-Almazán, V., Pérez-Correa, C., Rodríguez-Ortiz, U., Espinoza-Cárdenas, R., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1606-1 · Cited by 108
Wijeyekoon, R. S., Kronenberg-Versteeg, D., Scott, K. M., Hayat, S., Kuan, W.-L., Evans, J. R., Breen, D. P., Cummins, G., Jones, J. L., Clatworthy, M. R., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 104
Self-citationInflammaging markers characteristic of advanced age show similar levels with frailty and dependency
Alberro, A., Iribarren-Lopez, A., Sáenz-Cuesta, M., Matheu, A., Vergara, I., & Otaegui, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-83991-7 · Cited by 102
Abnormalities of age-related T cell senescence in Parkinson’s disease
Williams-Gray, C. H., Wijeyekoon, R. S., Scott, K. M., Hayat, S., Barker, R. A., & Jones, J. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1206-5 · Cited by 97 · cited 5×
“However, our previous data in two independent PD patient cohorts suggest that the relationship between CMV infection and CD8 T cell senescence is attenuated in PD compared to controls [29, 30].”
BackgroundResultSelf-citationStrazielle, N., Creidy, R., Malcus, C., Boucraut, J., & Ghersi-Egea, J.-F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150945 · Cited by 82
Apoptosis of peripheral blood lymphocytes in Parkinson patients
Calopa, M., Bas, J., Callén, A., & Mestre, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.017 · Cited by 81 · cited 1×
“Culturing T cells from PD patients both in the absence and presence of stimulation has indeed shown increased levels of apoptosis (as measured by the expression of annexin-V) when compared to cells from healthy individuals [81].”
Yu, S.-Y., Zuo, L.-J., Wang, F., Chen, Z.-J., Hu, Y., Wang, Y.-J., Wang, X.-M., & Zhang, W. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-113 · Cited by 79 · cited 3×
“Using a principal component analysis approach, we identified a proinflammatory immune marker profile characterised by high levels of IL-6, IFN , TNF , IL-2, IL-10, and CRP and low levels of IL-4 and IL-13, with prognostic significance.”
BackgroundJacquemont, L., Tilly, G., Yap, M., Doan-Ngoc, T.-M., Danger, R., Guérif, P., Delbos, F., Martinet, B., Giral, M., Foucher, Y., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019080847 · Cited by 78 · cited 1×
“CD8 TEMRAs remain highly cytotoxic on stimulation by their specific target antigen and they are known to contribute to certain disease states, for example they have been implicated in driving graft failure in renal transplant patients [82].”
BackgroundTelomere length in Parkinson's disease: A meta-analysis
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.002 · Cited by 70 · cited 1×
“The same authors performed a separate meta-analysis across 8 PD studies, concluding that there is no consistent evidence of telomere shortening in PD [74].”
Lifestyle exercise attenuates immunosenescence; flow cytometry analysis
Tylutka, A., Morawin, B., Gramacki, A., & Zembroń-Łacny, A. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02128-7 · Cited by 69 · cited 1×
“When sustained through life, physical activity can enhance the percentage of naı̈ve T lymphocyte population and reverse the CD4+ CD45RA+/CD4+ CD45RO+ ratio [88], alongside other immune changes (reviewed in [89]).”
BackgroundNissen, S. K., Farmen, K., Carstensen, M., Schulte, C., Goldeck, D., Brockmann, K., & Romero‐Ramos, M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.005 · Cited by 69 · cited 1×
“In PD, conventional myeloid dendritic cells (cDC2) responsible for priming CD4 T cells [40, 41] as well as, total myeloid dendritic cells have been found to be significantly decreased in PD compared to age-matched controls [42].”
ResultAssociation of the human leucocyte antigen region with susceptibility to Parkinson's disease
Saiki, M., Baker, A., Williams-Gray, C. H., Foltynie, T., Goodman, R. S., Taylor, C. J., Compston, D. A. S., Barker, R. A., Sawcer, S. J., & Goris, A. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.162883 · Cited by 68 · cited 1×
“This idea is supported by the well described genetic association between immune loci, particularly those involved in antigen presentation such as the Human Leucocyte Antigen region, and PD risk [79, 80].”
BackgroundSelf-citationImaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Lobanova, E., Whiten, D. R., Ruggeri, F. S., Taylor, C. G., Kouli, A., Xia, Z., Emin, D., Zhang, Y. P., Lam, J. Y. L., Williams‐Gray, C. H., et al. (2021) · Brain · doi:10.1093/brain/awab306 · Cited by 67 · cited 1×
“Alpha-synuclein aggregates, which are known to circulate in peripheral blood in PD [64], can induce a peripheral inflammatory response via Toll-like receptor activation [65].”
BackgroundSelf-citationCiaramella, A., Salani, F., Bizzoni, F., Pontieri, F. E., Stefani, A., Pierantozzi, M., Assogna, F., Caltagirone, C., Spalletta, G., & Bossù, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065352 · Cited by 65 · cited 1×
“In PD, conventional myeloid dendritic cells (cDC2) responsible for priming CD4 T cells [40, 41] as well as, total myeloid dendritic cells have been found to be significantly decreased in PD compared to age-matched controls [42].”
ResultAbnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study
Li, R., Tropea, T. F., Baratta, L. R., Zuroff, L. R., Diaz‐Ortiz, M. E., Zhang, B., Shinoda, K., Rezk, A., Alcalay, R. N., Chen‐Plotkin, A. S., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001125 · Cited by 62
van der Heiden, M., van Zelm, M. C., Bartol, S. J. W., de Rond, L. G. H., Berbers, G. A. M., Boots, A. M. H., & Buisman, A.-M. (2016) · Scientific Reports · doi:10.1038/srep26892 · Cited by 58 · cited 1×
“Both CD8 TEMRA and CD28loCD57hi T cell populations are increased in elderly CMV seropositive populations [19, 20].”
BackgroundA Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
Scott, K. M., Kouli, A., Yeoh, S. L., Clatworthy, M. R., & Williams-Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00815 · Cited by 58 · cited 1×
“This seems to be accompanied by an elevation of alphasynuclein auto-antibodies in early stages of PD that wanes as the disease progresses, according to our previous meta-analysis [78].”
ResultSelf-citationMartin-Ruiz, C., Williams-Gray, C. H., Yarnall, A. J., Boucher, J. J., Lawson, R. A., Wijeyekoon, R. S., Barker, R. A., Kolenda, C., Parker, C., Burn, D. J., et al. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191724 · Cited by 58
Self-citationIncreased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer’s Disease
Westman, G., Berglund, D., Widén, J., Ingelsson, M., Korsgren, O., Lannfelt, L., Sehlin, D., Lidehall, A.-K., & Eriksson, B.-M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096779 · Cited by 50 · cited 1×
“The same authors later showed that upon stimulation with T cell activating stimuli (anti-CD3/CD28 beads), PBMCs of CMV seropositive AD patients have a more inflammatory cytokine secretion profile compared to seropositive controls [72] providing further evidence of reduced immunosenescence.”
BackgroundT lymphocyte senescence is attenuated in Parkinson’s disease
Kouli, A., Jensen, M. P., Papastavrou, V., Scott, K. M., Kolenda, C., Parker, C., Solim, I. H., Camacho, M., Martin-Ruiz, C. M., & Williams‐Gray, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02287-9 · Cited by 48
Self-citationThe TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
Singhania, A., Pham, J. W., Dhanwani, R., Frazier, A., Dutra, J. R., Marder, K. S., Phillips, E. J., Mallal, S. A., Amara, A. W., Standaert, D. G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79726-9 · Cited by 41 · cited 1×
“a very diverse repertoire of T cell receptors [77].”
BackgroundVandenberk, B., Brouwers, B. A. H., Hatse, S., & Wildiers, H. P. M. W. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.08.004 · Cited by 40 · cited 1×
“In CD8 T lymphocytes, we observed a significant decrease in the mRNA levels of cyclin-dependent kinase inhibitor p16INK4a, a well-established marker of cellular senescence, in PD cases compared to controls [31].”
ResultMondello, S., Kobeissy, F. H., Mechref, Y. S., Zhao, J., Talih, F. R., Cosentino, F., Antelmi, E., Moresco, M., Plazzi, G., & Ferri, R. (2018) · Neurology · doi:10.1212/wnl.0000000000006439 · Cited by 35 · cited 1×
“Interestingly, a proteomic study in a small group of patients with REM sleep behaviour disorder (who have a 60–81% likelihood of developing parkinsonism/dementia within 10 years) [55, 56] has reported a significant upregulation of CRP as well as other immune-related molecules in patients versus controls, thus implicat…”
BackgroundNo evidence of substantia nigra telomere shortening in Parkinson's disease
Hudson, G., Faini, D., Stutt, A., Eccles, M., Robinson, L., Burn, D. J., & Chinnery, P. F. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.022 · Cited by 33 · cited 1×
“, compared telomere lengths in peripheral blood mononuclear cells of 109 PD cases and 99 controls and reported significantly longer telomeres in PD patients versus controls, consistent with reduced leucocyte senescence [48].”
ResultDegerman, S., Domellöf, M., Landfors, M., Linder, J., Lundin, M., Haraldsson, S., Elgh, E., Roos, G., & Forsgren, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113387 · Cited by 32
Westman, G., Lidehall, A.-K., Magnusson, P., Ingelsson, M., Kilander, L., Lannfelt, L., Korsgren, O., & Eriksson, B.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077921 · Cited by 24 · cited 1×
“showed that latent CMV infection was associated with a decreased proportion of CMVspecific CD8 T lymphocytes in AD patients compared to controls, [71] mirroring our findings of a reduced senescent shift in the T cell population in response to CMV infection in PD [29, 30].”
ResultVavilova, J. D., Boyko, A. A., Пономарева, Н. В., Fokin, V. F., Fedotova, E. Y., Streltsova, M. A., Kust, S. A., Grechikhina, M. V., Витальевна, Б. Е., Zimnyakova, O. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313119 · Cited by 20 · cited 2×
“We and others have shown that in the context of prior CMV infection (indicated by CMV IgG positivity), the expected accumulation of CD8 senescent T cells is not observed in PD patients [29, 30, 32].”
BackgroundEssential Microenvironment for Thymopoiesis is Preserved in Human Adult and Aged Thymus
Shiraishi, J., Utsuyama, M., Seki, S., Akamatsu, H., Sunamori, M., Kasai, M., & Hirokawa, K. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001598465 · Cited by 19 · cited 1×
“Thymic involution has been shown to start very early on in life and continue exponentially over time [24, 25].”
Background
Cited by
The pathogenesis of Parkinson's disease
Morris, H. R., Spillantini, M. G., Sue, C. M., & Williams-Gray, C. H. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01478-2 · Cited by 1,019
Self-citationAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“…the CD8 + T-cell population may be attenuated, resulting in a heightened immune response to misfolded α -syn and thereby increasing the risk of PD. 333 Similarly, in a single-centre, retrospective study, increased numbers of senescent and late memory T and B lymphocytes were characteristic of…”
InfluentialLv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 125
“As age is the main risk factor for PD [26], the microglia in the brain of older people present changes in morphology, phenotype, inflammation and overall functional response.”
BackgroundZaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03007-1 · Cited by 25
“Such impact of age-related dysregulated T-cell effector functions were recently observed in patients with ALS [29] and several neurodegenerative processes such as MS [54], PD [55], and AD [56].”
BackgroundMapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing
Moquin‐Beaudry, G., Andriamboavonjy, L., Audet, S., Hamilton, L. K., Duquette, A., Chouinard, S., Panisset, M., & Tétreault, M. (2025) · Brain · doi:10.1093/brain/awaf066 · Cited by 25
Metadata
- Authors
- Kouli, A., & Williams-Gray, C. H.
- Affiliations
- University of Cambridge (GB)
- Department of Clinical Neurosciences, University of Cambridge, John Van Geest Centre for Brain Repair, Cambridge, UK
- Corresponding author
- Kouli, Antonina
- ORCID
- Kouli, Antonina
- Venue
- Journal of Parkinson's Disease
- Publisher
- SAGE Publications
- Published
- 2022-09-27
- Volume
- 12
- Issue
- s1
- Pages
- S93-S104
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC9535571
- OpenAlex
- W4281741142
- Cited by
- 20
- References
- 94
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 10 · 2023: 2 · 2022: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- Apollo (cc-by)
- Funders
- UK Research and Innovation
- National Institute for Health and Care Research ([IS-BRC-1215-20014, BRC1215-20014)
- Research Councils UK
- Medical Research Council (MR/R007446/1, BRC-1215-20014)
- NIHR Cambridge Biomedical Research Centre ((BRC-1215-20014))
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- Parkinson's disease, immunosenescence, age-related immune changes, T cell senescence, CD8+ T cells, neuroinflammation, neurodegeneration, pathogenesis
- MeSH terms
- Immunosenescence, Aged, Aging, Humans, Parkinson Disease, T-Lymphocytes, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.